Cisplatin: an important representative and application overview of anticancer drugs

Cisplatin is a platinum-based chemotherapy drug widely used in cancer treatment. It is mainly used to treat various malignant tumors such as testicular cancer, ovarian cancer, and bladder cancer. Its mechanism of action is to inhibit tumor cell proliferation by combining with DNA to form cross-links. This article will start from the discovery process, pharmacological effects, clinical applications and manufacturers of cisplatin, focusing on analyzing its core position and precautions in tumor treatment.

Discovery and pharmacological mechanism of cisplatin

The discovery of cisplatin originated from an unexpected discovery made by Professor Rosenberg of Michigan State University in 1965 while studying the effects of electric fields on bacterial growth. In the experiment, it was found that the compounds produced around the platinum electrode could inhibit cell division, and the active ingredient cisplatin was finally isolated. Its anti-cancer mechanism is through the combination of platinum atoms and DNA bases to form intra-chain or inter-chain cross-links, blocking DNA replication and transcription, thereby inducing tumor cell apoptosis. It is worth noting that cisplatin is effective against a variety of solid tumors, but it is accompanied by side effects such as nephrotoxicity and neurotoxicity, and strict monitoring of medication is required.

Clinical applications and treatment options

Cisplatin is included in the World Health Organization's Essential Medicines List and is often used in combination with other drugs (such as etoposide, paclitaxel) to enhance its efficacy. In the treatment of testicular cancer, the cisplatin combination regimen increases the cure rate to more than 90%; for patients with advanced ovarian cancer, cisplatin-containing chemotherapy can significantly prolong survival. For clinical use, the dose needs to be adjusted according to the patient's constitution, and supplemented with hydration therapy and antiemetic drugs to reduce adverse reactions. In recent years, new drug delivery methods such as nanocarrier technology are being studied to improve targeting and reduce toxicity.

Manufacturers and market status

Summary and Outlook

As a landmark drug in the field of chemotherapy, although cisplatin faces competition from new targeted therapies, it is still irreplaceable in terms of economy and broad spectrum. Future research will focus on reducing toxic side effects and combining immunotherapy. Patients must strictly follow the doctor's instructions when taking medication and weigh the efficacy and safety. Its scientific value and clinical contribution have been confirmed by multiple studies, and it continues to provide important support for the anti-cancer cause.

Citing sources

1. Rosenberg B, et al.Nature(1965), who discovered the anticancer effects of cisplatin
2. World Health Organization Model List of Essential Medicines (2023 Edition)
3. Cisplatin drug instructions approved by the National Medical Products Administration
4. Journal of Clinical Oncology "Meta-Analysis of Cisplatin Combination Regimen in the Treatment of Advanced Ovarian Cancer" (2021)